- Home
- TECH vs EQX Comparison
TECH vs EQX Comparison
Compare TECH & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TECH | EQX |
|---|---|---|
| Founded | 1976 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 13.5B |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TECH | EQX |
|---|---|---|
| Price | $72.60 | $10.14 |
| Analyst Decision | Hold | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $70.50 | N/A |
| AVG Volume (30 Days) | 2.6M | ★ 9.6M |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | 0.44% | ★ 0.51% |
| EPS Growth | ★ 152.17 | N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $1,215,039,000.00 | N/A |
| Revenue This Year | $4.35 | $113.43 |
| Revenue Next Year | $10.04 | $28.69 |
| P/E Ratio | ★ $62.64 | $137.41 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $43.20 | $8.49 |
| 52 Week High | $72.69 | $18.96 |
Technical Indicators
Market Signals| Indicator | TECH | EQX |
|---|---|---|
| Relative Strength Index (RSI) | 56.95 | 36.76 |
| Support Level | $72.36 | $9.34 |
| Resistance Level | $72.63 | $10.49 |
| Average True Range (ATR) | 0.12 | 0.43 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 64.28 | 9.63 |
Price Performance
Historical ComparisonAbout TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. The company operates gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the Canada, United States, Mexico, and others. The majority of its revenue is generated from Canada.